Combination treatment with Tecvayli (teclistamab-cqyv) and Darzalex Faspro (daratumumab and hyaluronidase-fihj) led to a 100% response rate for 49 people with newly diagnosed…
Myeloma
When my mum, Esther, was diagnosed with myeloma in January 2021, our world split in two. There was the life we thought we were…
I recently went to the supermarket to pick up some groceries. While I was shopping for avocados, an acquaintance approached me. “How is your mother?”…
Over a 15-year period, the median survival time for people with myeloma has nearly doubled, increasing from 2.4 years for those diagnosed in 2005…
It started like any ordinary ache — something my mum, Esther, was all too familiar with. She often woke up with a crick in her…
The first time I saw a patient all by himself in the infusion room, I didn’t notice him. No, that’s not what happened. On that…
The U.S. Food and Drug Administration (FDA) has approved two new biosimilar drugs — versions of brand-name therapies that have no clinically meaningful differences compared…
At my last school reunion, someone asked me, “What do you do?” “I am a writer and a columnist,” I said. At the coffee…
This September, during Blood Cancer Awareness Month, major organizations are launching new campaigns to increase awareness and support for the three main types of…
Last year, while I was attending a fundraiser for breast cancer, I watched several hundred people adorned in pink shirts cheering with joy and excitement…
Recent Posts
- Navigating hair loss, and regrowth, after SCT for multiple myeloma
- Trial testing cell therapy for hard-to-treat AML now full in both countries
- FDA approves electrical field therapy Optune Pax for pancreatic cancer
- The importance of finding your anchor in the storm of caregiving
- Trial of glioma drug safusidenib to add patients, move to Phase 3
